These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 23494361)
1. Low ADAMTS-13 activity during hemorrhagic events with disseminated intravascular coagulation. Chinen Y; Kuroda J; Ohshiro M; Shimura Y; Mizutani S; Nagoshi H; Sasaki N; Nakayama R; Kiyota M; Yamamoto-Sugitani M; Kobayashi T; Matsumoto Y; Horiike S; Taniwaki M Int J Hematol; 2013 Apr; 97(4):511-9. PubMed ID: 23494361 [TBL] [Abstract][Full Text] [Related]
2. Clinical features and outcomes of 35 disseminated intravascular coagulation cases treated with recombinant human soluble thrombomodulin at a single institution. Kawano N; Yoshida S; Ono N; Himeji D; Nagahiro Y; Sayaka Kawano ; Yamashita K; Ikeda N; Uezono S; Ochiai H; Kawano F; Kikuchi I; Ishikawa F; Shimoda K; Ueda A; Akashi K J Clin Exp Hematop; 2011; 51(2):101-7. PubMed ID: 22104308 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of Combined Thrombomodulin and Antithrombin in Anticoagulant Therapy for Acute Cholangitis-induced Disseminated Intravascular Coagulation. Morita N; Nakahara K; Morita R; Suetani K; Michikawa Y; Sato J; Tsuji K; Ikeda H; Matsunaga K; Watanabe T; Matsumoto N; Okuse C; Suzuki M; Itoh F Intern Med; 2019 Apr; 58(7):907-914. PubMed ID: 30449812 [TBL] [Abstract][Full Text] [Related]
4. Multicenter clinical experience with recombinant soluble thrombomodulin for disseminated intravascular coagulation associated with severe acute cholecystitis. Ogura T; Eguchi T; Amano M; Sano T; Nishioka N; Miyano A; Tsujimae M; Tanimura H; Yamada T; Terashima Y; Okada A; Higuchi K Thromb Res; 2019 Apr; 176():74-78. PubMed ID: 30780007 [TBL] [Abstract][Full Text] [Related]
5. Effect of Recombinant Human Soluble Thrombomodulin on Coagulation-Related Variables in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Retrospective Observational Study. Mitaka C; Kawagoe I; Satoh D; Hayashida M Clin Appl Thromb Hemost; 2021; 27():10760296211050356. PubMed ID: 34859680 [TBL] [Abstract][Full Text] [Related]
6. [Efficacy of Recombinant Thrombomodulin for Sepsis-Associated Disseminated Intravascular Coagulation Caused by Urinary Tract Infections]. Tachibana A; Iida K; Itami Y; Hashimura M; Toyoshima Y; Hosokawa Y; Fujimoto K Hinyokika Kiyo; 2023 Nov; 69(11):309-314. PubMed ID: 38031329 [TBL] [Abstract][Full Text] [Related]
7. Effects of recombinant human soluble thrombomodulin treatment for disseminated intravascular coagulation at a single institution--an analysis of 62 cases caused by infectious diseases and 30 cases caused by hematological diseases. Kawano N; Tasaki A; Kuriyama T; Tahara Y; Yoshida S; Ono N; Himeji D; Yamashita K; Shibata Y; Goto T; Inoue T; Yokota-Ikeda N; Uezono S; Yuge A; Nishiguchi T; Kinjo T; Ogura Y; Beppu K; Ueda Y; Kinoshita M; Moritake H; Shimoda K; Ochiai H; Ueda A Intern Med; 2014; 53(3):205-13. PubMed ID: 24492688 [TBL] [Abstract][Full Text] [Related]
8. Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia. Ookura M; Hosono N; Tasaki T; Oiwa K; Fujita K; Ito K; Lee S; Matsuda Y; Morita M; Tai K; Negoro E; Kishi S; Iwasaki H; Ueda T; Yamauchi T Medicine (Baltimore); 2018 Nov; 97(44):e12981. PubMed ID: 30383650 [TBL] [Abstract][Full Text] [Related]
9. Correlation between plasma activity of ADAMTS-13 and coagulopathy, and prognosis in disseminated intravascular coagulation. Hyun J; Kim HK; Kim JE; Lim MG; Jung JS; Park S; Cho HI Thromb Res; 2009 May; 124(1):75-9. PubMed ID: 19162307 [TBL] [Abstract][Full Text] [Related]
10. ADAMTS-13 activity can predict the outcome of disseminated intravascular coagulation in hematologic malignancies treated with recombinant human soluble thrombomodulin. Ohshiro M; Kuroda J; Kobayashi Y; Akaogi T; Kawata E; Uoshima N; Kamitsuji Y; Kaneko H; Shimura K; Shimazaki C; Murakami S; Hatsuse M; Okano A; Kobayashi T; Uchiyama H; Matsumoto Y; Horiike S; Taniwaki M Am J Hematol; 2012 Jan; 87(1):116-9. PubMed ID: 21989545 [No Abstract] [Full Text] [Related]
11. Comparison of recombinant human thrombomodulin and gabexate mesylate for treatment of disseminated intravascular coagulation (DIC) with sepsis following emergent gastrointestinal surgery: a retrospective study. Akahoshi T; Sugimori H; Kaku N; Tokuda K; Nagata T; Noda E; Morita M; Hashizume M; Maehara Y Eur J Trauma Emerg Surg; 2015 Oct; 41(5):531-8. PubMed ID: 26038004 [TBL] [Abstract][Full Text] [Related]
12. [The efficacy of early use of recombinant soluble thrombomodulin for disseminated intravascular coagulation complicated with hematologic malignancies]. Usami M; Kuroda H; Yoshida M; Sakamoto H; Shimoyama S; Kanari Y; Yamada M; Abe T; Fujii S; Maeda M Rinsho Ketsueki; 2015 Jun; 56(6):673-80. PubMed ID: 26256878 [TBL] [Abstract][Full Text] [Related]
13. Thrombomodulin in the management of acute cholangitis-induced disseminated intravascular coagulation. Suetani K; Okuse C; Nakahara K; Michikawa Y; Noguchi Y; Suzuki M; Morita R; Sato N; Kato M; Itoh F World J Gastroenterol; 2015 Jan; 21(2):533-40. PubMed ID: 25593469 [TBL] [Abstract][Full Text] [Related]
14. Clinical Impact of Recombinant Soluble Thrombomodulin for Disseminated Intravascular Coagulation Associated with Severe Acute Cholangitis. Okuda A; Ogura T; Imanishi M; Miyano A; Nishioka N; Higuchi K Gut Liver; 2018 Jul; 12(4):471-477. PubMed ID: 29699063 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of recombinant human soluble thrombomodulin in severe postpartum hemorrhage with disseminated intravascular coagulation. Sugawara J; Suenaga K; Hoshiai T; Sato T; Nishigori H; Nagase S; Yaegashi N Clin Appl Thromb Hemost; 2013 Sep; 19(5):557-61. PubMed ID: 22496090 [TBL] [Abstract][Full Text] [Related]
16. Impact of Recombinant Human Soluble Thrombomodulin for Disseminated Intravascular Coagulation. Itoh S; Shirabe K; Kohnoe S; Sadanaga N; Kajiyama K; Yamagata M; Anai H; Harimoto N; Ikegami T; Yoshizumi T; Maehara Y Anticancer Res; 2016 May; 36(5):2493-6. PubMed ID: 27127163 [TBL] [Abstract][Full Text] [Related]
17. Retrospective analysis on the clinical outcomes of recombinant human soluble thrombomodulin for disseminated intravascular coagulation syndrome associated with solid tumors. Ouchi K; Takahashi S; Chikamatsu S; Ito S; Takahashi Y; Kawai S; Okita A; Kasahara Y; Okada Y; Imai H; Komine K; Saijo K; Takahashi M; Shirota H; Takahashi M; Gamoh M; Ishioka C Int J Clin Oncol; 2018 Aug; 23(4):790-798. PubMed ID: 29511940 [TBL] [Abstract][Full Text] [Related]
18. [Successful treatment with recombinant thrombomodulin for disseminated intravascular coagulation complicated with hemophagocytic syndrome]. Yamazaki H; Kondo T; Tatsumi G; Kotani S; Arai Y; Shirakawa K; Kitano T; Hishizawa M; Kadowaki N; Takaori-Kondo A Rinsho Ketsueki; 2015 Mar; 56(3):312-6. PubMed ID: 25876785 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial. Saito H; Maruyama I; Shimazaki S; Yamamoto Y; Aikawa N; Ohno R; Hirayama A; Matsuda T; Asakura H; Nakashima M; Aoki N J Thromb Haemost; 2007 Jan; 5(1):31-41. PubMed ID: 17059423 [TBL] [Abstract][Full Text] [Related]
20. Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort. Matsushita T; Watanabe J; Honda G; Mimuro J; Takahashi H; Tsuji H; Eguchi Y; Kitajima I; Sakata Y Thromb Res; 2014 May; 133(5):772-81. PubMed ID: 24636871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]